LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced today the introduction of the newest addition to its clinically proven line of topical products to treat acne – CLENZIderm M.D.™ Acne Therapeutic System for Normal to Dry Skin. This simple three-step system, based on Obagi’s patent-pending, solubilized benzoyl peroxide, penetrates deep and clears acne fast, while minimizing dryness and maximizing patient comfort.
